Circulating Fatty Acid-binding Protein 4 Response to Acute Aerobic Exercise in Healthy Men

Abstract

This study aimed to investigate the association between changes in FABP4 concentration and hormone and metabolite levels during and after acute low- and moderate-intensity aerobic exercise in healthy men. Eleven healthy men (24.4±1.4 years) were administered three trials in random order: 1) low-intensity aerobic exercise trial (LE trial; acute exercise at 40% peak oxygen uptake [Vo₂peak]+bed rest), 2) moderate-intensity aerobic exercise trial (ME trial: acute exercise at 60%Vo₂peak+bed rest), and 3) bed rest (Con trial). Expired gas and venous blood samples were collected at baseline, and immediately, 30 and 60 min after exercise, and substrate oxidation and hormone, metabolite, and FABP4 concentrations were measured. FABP4 concentration did not increase during aerobic exercise in LE and ME trials (p>0.05). However, FABP4 concentration significantly increased after the acute aerobic exercise in both the LE and ME trials (p≤0.003). Increased FABP4 concentration after acute exercise was not correlated with adrenaline, noradrenaline, other hormone, and metabolite concentration changes. These findings suggest that FABP4 concentration increases after acute aerobic exercise independently of exercise intensity. Furthermore, increased FABP4 concentration after acute aerobic exercise may not be involved in the magnitude of adrenaline, noradrenaline, and lipolytic response.

Key words

fatty acid-binding protein - glucose - lipolysis - catecholamine - troponin T

Publication History

Received: 27 October 2022

Accepted: 17 January 2023

Accepted Manuscript online:
19 January 2023

Article published online:
21 April 2023

• References

• 1 Furuhashi M, Saitoh S, Shimamoto K. et al. Fatty acid-binding protein 4 (FABP4): Pathophysiological insights and potent clinical biomarker of metabolic and cardiovascular diseases. Clin Med Insights Cardiol 2014; 8: 23-33
• 2 Baxa CA, Sha RS, Buelt MK. et al. Human adipocyte lipid-binding protein: purification of the protein and cloning of its complementary DNA. Biochemistry 1989; 28: 8683-8690
• 3 Hunt CR, Ro JH, Dobson DE. et al. Adipocyte P2 gene: developmental expression and homology of 5'-flanking sequences among fat cell-specific genes. Proc Natl Acad Sci U S A 1986; 83: 3786-3790
• 4 Spiegelman BM, Frank M, Green H.. Molecular cloning of mRNA from 3T3 adipocytes. Regulation of mRNA content for glycerophosphate dehydrogenase and other differentiation-dependent proteins during adipocyte development. J Biol Chem 1983; 258: 10083-10089
• 5 Cao H, Sekiya M, Ertunc ME. et al. Adipocyte lipid chaperone AP2 is a secreted adipokine regulating hepatic glucose production. Cell Metab 2013; 17: 768-778
• 6 Mita T, Furuhashi M, Hiramitsu S. et al. FABP4 is secreted from adipocytes by adenyl cyclase-PKA- and guanylyl cyclase-PKG-dependent lipolytic mechanisms. Obesity (Silver Spring) 2015; 23: 359-367
• 7 Furuhashi M, Yuda S, Muranaka A. et al. Circulating fatty acid-binding protein 4 concentration predicts the progression of carotid atherosclerosis in a general population without medication. Circ J 2018; 82: 1121-1129
• 8 Yeung DC, Xu A, Cheung CW. et al. Serum adipocyte fatty acid-binding protein levels were independently associated with carotid atherosclerosis. Arterioscler Thromb Vasc Biol 2007; 27: 1796-1802
• 9 Xu A, Wang Y, Xu JY. et al. Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin Chem 2006; 52: 405-413
• 10 Haluzik MM, Anderlova K, Dolezalova R. et al. Serum adipocyte fatty acid binding protein levels in patients with type 2 diabetes mellitus and obesity: the influence of fenofibrate treatment. Physiol Res 2009; 58: 93-99
• 11 Ota H, Furuhashi M, Ishimura S. et al. Elevation of fatty acid-binding protein 4 is predisposed by family history of hypertension and contributes to blood pressure elevation. Am J Hypertens 2012; 25: 1124-1130
• 12 Furuhashi M, Omori A, Matsumoto M. et al. Independent link between levels of proprotein convertase Subtilisin/Kexin Type 9 and FABP4 in a general population without medication. Am J Cardiol 2016; 118: 198-203
• 13 von Eynatten M, Breitling LP, Roos M. et al. Circulating adipocyte fatty acid-binding protein levels and cardiovascular morbidity and mortality in patients with coronary heart disease: a 10-year prospective study. Arterioscler Thromb Vasc Biol 2012; 32: 2327-2335
• 14 Chow WS, Tso AW, Xu A. et al. Elevated circulating adipocyte-fatty acid binding protein levels predict incident cardiovascular events in a community-based cohort: a 12-year prospective study. J Am Heart Assoc 2013; 2: e004176
• 15 Guaita-Esteruelas S, Saavedra-Garcia P, Bosquet A. et al. Adipose-derived fatty acid-binding proteins plasma concentrations are increased in breast cancer patients. Oncologist 2017; 22: 1309-1315
• 16 Furuhashi M, Ishimura S, Ota H. et al. Serum fatty acid-binding protein 4 is a predictor of cardiovascular events in end-stage renal disease. PLoS One 2011; 6: e27356
• 17 Rodriguez-Calvo R, Girona J, Alegret JM. et al. Role of the fatty acid-binding protein 4 in heart failure and cardiovascular disease. J Endocrinol 2017; 233: R173-R184
• 18 Wu LE, Samocha-Bonet D, Whitworth PT. et al. Identification of fatty acid binding protein 4 as an adipokine that regulates insulin secretion during obesity. Mol Metab 2014; 3: 465-473
• 19 Makowski L, Brittingham KC, Reynolds JM. et al. The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor gamma and IkappaB kinase activities. J Biol Chem 2005; 280: 12888-12895
• 20 Furuhashi M, Fuseya T, Murata M. et al. Local production of fatty acid-binding protein 4 in epicardial/perivascular fat and macrophages is linked to coronary atherosclerosis. Arterioscler Thromb Vasc Biol 2016; 36: 825-834
• 21 Guaita-Esteruelas S, Bosquet A, Saavedra P. et al. Exogenous FABP4 increases breast cancer cell proliferation and activates the expression of fatty acid transport proteins. Mol Carcinog 2017; 56: 208-217
• 22 Thompson PD, Crouse SF, Goodpaster B. et al. The acute versus the chronic response to exercise. Med Sci Sports Exerc 2001; 33: S438-S445 discussion S452-433
• 23 Iso T, Sunaga H, Matsui H. et al. Serum levels of fatty acid binding protein 4 and fat metabolic markers in relation to catecholamines following exercise. Clin Biochem 2017; 50: 896-902
• 24 Numao S, Uchida R, Kurosaki T. et al. Circulating fatty acid binding protein 4 concentration increases with an acute maximal exercise independently of exercise training status. International Journal of Sport and Health Science 2020; 18: 237-246
• 25 Ertunc ME, Sikkeland J, Fenaroli F. et al. Secretion of fatty acid binding protein aP2 from adipocytes through a nonclassical pathway in response to adipocyte lipase activity. J Lipid Res 2015; 56: 423-434
• 26 Arner P, Kriegholm E, Engfeldt P. et al. Adrenergic regulation of lipolysis in situ at rest and during exercise. J Clin Invest 1990; 85: 893-898
• 27 Moro C, Pillard F, de Glisezinski I. et al. Exercise-induced lipid mobilization in subcutaneous adipose tissue is mainly related to natriuretic peptides in overweight men. Am J Physiol Endocrinol Metab 2008; 295: E505-E513
• 28 Romijn JA, Coyle EF, Sidossis LS. et al. Regulation of endogenous fat and carbohydrate metabolism in relation to exercise intensity and duration. Am J Physiol 1993; 265: E380-E391
• 29 Harriss DJ, Jones C, MacSween A.. Ethical standards in sport and exercise science research: 2022 update. Int J Sports Med 2022; 43: 1065-1070
• 30 Colakoglu M, Ozkaya O, Balci GA. et al. Shorter intervals at peak SV vs.VO2max may yield high SV with less physiological stress. Eur J Sport Sci 2015; 15: 623-630
• 31 van Loon LJ, Greenhaff PL, Constantin-Teodosiu D. et al. The effects of increasing exercise intensity on muscle fuel utilisation in humans. J Physiol 2001; 536: 295-304
• 32 Dill DB, Costill DL.. Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration. J Appl Physiol 1974; 37: 247-248
• 33 Friedewald WT, Levy RI, Fredrickson DS.. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502
• 34 Moro C, Crampes F, Sengenes C. et al. Atrial natriuretic peptide contributes to physiological control of lipid mobilization in humans. FASEB J 2004; 18: 908-910
• 35 Farquhar WB, Kenney WL.. Age and renal prostaglandin inhibition during exercise and heat stress. J Appl Physiol (1985) 1999; 86: 1936-1943
• 36 Makowski L, Boord JB, Maeda K. et al. Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat Med 2001; 7: 699-705
• 37 Shum BO, Mackay CR, Gorgun CZ. et al. The adipocyte fatty acid-binding protein aP2 is required in allergic airway inflammation. J Clin Invest 2006; 116: 2183-2192
• 38 Woods JA.. Exercise and neuroendocrine modulation of macrophage function. Int J Sports Med 2000; 21: S24-S30
• 39 Ciardi C, Tatarczyk T, Tschoner A. et al. Effect of postprandial lipemia on plasma concentrations of A-FABP, RBP-4 and visfatin. Nutr Metab Cardiovasc Dis 2010; 20: 662-668
• 40 Lamounier-Zepter V, Look C, Alvarez J. et al. Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction: a new link between obesity and heart disease. Circ Res 2009; 105: 326-334